Qiagen (QGEN) Q2 FY26 earnings call

Qiagen delivered Q2 FY26 results above its sales and adjusted EPS outlook, driven by strong performance in its growth pillars like Sample Technologies and QIAcuity. The company reaffirmed its full-year guidance, anticipating a stronger second half fueled by new product launches and easing comparisons, despite continued caution regarding overall funding environments. Management emphasized disciplined execution and strategic investments to maintain high profitability and shareholder returns.